Chimeric antigen receptor (CAR)-T cell adoptive immunotherapy is a promising cancer treatment that uses genetically engineered T cells to attack tumors. However, this therapy can have some adverse effects. CAR-T cell-derived exosomes are a potential alternative to CAR-T cells that may overcome some ...
Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!